Security key
74587V107
PUMA BIOTECHNOLOGY, INC. - Common Stock (PBYI)
CUSIP: 74587V107
Q1 2018 13F Holders as of 31 Mar 2018
- Type / Class
- Equity / Common Stock
- Shares outstanding
- 49,633,071
- Total 13F shares
- 35,574,353
- Share change
- -545,175
- Total reported value
- $2,419,811,616
- Put/Call ratio
- 180%
- Price per share
- $68.05
- Number of holders
- 168
- Value change
- -$81,238,705
- Number of buys
- 104
- Number of sells
- 94
Report period
Q1 2018
Institutions
168
Top holders
10
PBYI full security history
Newer quarter: Q2 2018
Previous quarter: Q4 2017
PUMA BIOTECHNOLOGY, INC. SEC filings
PUMA BIOTECHNOLOGY, INC. company facts
Broader feeds
Reporting periods
Holder history for CUSIP 74587V107
Recent filing periods:
Top shareholders of PBYI - PUMA BIOTECHNOLOGY, INC. - Common Stock (13F + 13D/G + 3/4/5)
Grouped by holder across the latest SEC ownership disclosures. Ownership % is shown only when it is directly reported or safely comparable across share classes.
Methodology: rows are grouped by holder and ranked first by SEC-reported ownership % when it is safely comparable, then by disclosed holdings value. — indicates unavailable or non-comparable values; "mixed-class rows" means the latest filing spans non-comparable classes.
| Holder | Source | Role / Reporting | Ownership % | Shares | Holdings Value | 12M Net Δ | As of | Details |
|---|---|---|---|---|---|---|---|---|
| JANUS HENDERSON GROUP PLC |
13F
|
Company |
8.8%
|
4,355,643
|
$430,555,000 | — | 31 Dec 2017 | |
| VANGUARD GROUP INC |
13F
|
Company |
5.3%
|
2,615,069
|
$258,500,000 | — | 31 Dec 2017 | |
| BlackRock Finance, Inc. |
13F
|
Company |
4.8%
|
2,385,036
|
$235,763,000 | — | 31 Dec 2017 | |
| ADAGE CAPITAL PARTNERS GP, L.L.C. |
13F
|
Company |
4.5%
|
2,222,500
|
$219,694,000 | — | 31 Dec 2017 | |
| ORBIMED ADVISORS LLC |
13F
|
Company |
4.4%
|
2,184,535
|
$215,941,000 | — | 31 Dec 2017 | |
| PRICE T ROWE ASSOCIATES INC /MD/ |
13F
|
Company |
4%
|
1,976,517
|
$195,379,000 | — | 31 Dec 2017 | |
| PFM Health Sciences, LP |
13F
|
Company |
3.7%
|
1,821,800
|
$180,085,000 | — | 31 Dec 2017 | |
| FMR LLC |
13F
|
Company |
3.4%
|
1,708,154
|
$168,851,000 | — | 31 Dec 2017 | |
| STATE STREET CORP |
13F
|
Company |
2.4%
|
1,187,559
|
$117,394,000 | — | 31 Dec 2017 | |
| D. E. Shaw & Co., Inc. |
13F
|
Company |
1.9%
|
946,578
|
$93,570,000 | — | 31 Dec 2017 | |
| Redmile Group, LLC |
13F
|
Company |
1.8%
|
913,573
|
$90,307,000 | — | 31 Dec 2017 | |
| CITADEL ADVISORS LLC |
13F
|
Company |
1.7%
|
836,925
|
$82,730,000 | — | 31 Dec 2017 | |
| FRANKLIN RESOURCES INC |
13F
|
Company |
1.7%
|
834,400
|
$82,480,000 | — | 31 Dec 2017 | |
| NORGES BANK |
13F
|
Company |
1.4%
|
716,003
|
$70,778,000 | — | 31 Dec 2017 | |
| PERCEPTIVE ADVISORS LLC |
13F
|
Company |
1.4%
|
703,820
|
$69,573,000 | — | 31 Dec 2017 | |
| WELLS FARGO & COMPANY/MN |
13F
|
Company |
1.1%
|
524,933
|
$51,890,000 | — | 31 Dec 2017 | |
| GOLDMAN SACHS GROUP INC |
13F
|
Company |
1%
|
500,386
|
$49,463,000 | — | 31 Dec 2017 | |
| Polar Capital LLP |
13F
|
Company |
0.9%
|
445,000
|
$43,988,000 | — | 31 Dec 2017 | |
| EMERALD ADVISERS, LLC |
13F
|
Company |
0.81%
|
402,668
|
$39,804,000 | — | 31 Dec 2017 | |
| Rock Springs Capital Management LP |
13F
|
Company |
0.75%
|
373,500
|
$36,920,000 | — | 31 Dec 2017 | |
| SCHRODER INVESTMENT MANAGEMENT GROUP |
13F
|
Company |
0.69%
|
341,790
|
$33,786,000 | — | 31 Dec 2017 | |
| NORTHERN TRUST CORP |
13F
|
Company |
0.68%
|
336,727
|
$33,285,000 | — | 31 Dec 2017 | |
| AMERIPRISE FINANCIAL INC |
13F
|
Company |
0.66%
|
328,063
|
$32,428,000 | — | 31 Dec 2017 | |
| EMERALD MUTUAL FUND ADVISERS TRUST |
13F
|
Company |
0.65%
|
320,343
|
$31,666,000 | — | 31 Dec 2017 | |
| EAGLE ASSET MANAGEMENT INC |
13F
|
Company |
0.6%
|
297,620
|
$28,918,000 | — | 31 Dec 2017 | |
| GEODE CAPITAL MANAGEMENT, LLC |
13F
|
Company |
0.59%
|
290,691
|
$28,733,000 | — | 31 Dec 2017 | |
| DEUTSCHE BANK AG\ |
13F
|
Company |
0.54%
|
267,986
|
$26,489,000 | — | 31 Dec 2017 | |
| MILLENNIUM MANAGEMENT LLC |
13F
|
Company |
0.53%
|
263,204
|
$26,018,000 | — | 31 Dec 2017 | |
| Point72 Asset Management, L.P. |
13F
|
Company |
0.53%
|
260,852
|
$25,785,000 | — | 31 Dec 2017 | |
| VOYA INVESTMENT MANAGEMENT LLC |
13F
|
Company |
0.51%
|
253,007
|
$25,009,000 | — | 31 Dec 2017 | |
| SUSQUEHANNA INTERNATIONAL GROUP, LLP |
13F
|
Company |
0.47%
|
231,821
|
$22,916,000 | — | 31 Dec 2017 | |
| PointState Capital LP |
13F
|
Company |
0.45%
|
225,232
|
$22,264,000 | — | 31 Dec 2017 | |
| BANK OF AMERICA CORP /DE/ |
13F
|
Company |
0.45%
|
223,849
|
$22,128,000 | — | 31 Dec 2017 | |
| MORGAN STANLEY |
13F
|
Company |
0.45%
|
223,257
|
$22,069,000 | — | 31 Dec 2017 | |
| CARILLON TOWER ADVISERS, INC. |
13F
|
Company |
0.42%
|
207,820
|
$20,543,000 | — | 31 Dec 2017 | |
| UBS Group AG |
13F
|
Company |
0.39%
|
192,480
|
$19,027,000 | — | 31 Dec 2017 | |
| FRED ALGER MANAGEMENT, LLC |
13F
|
Company |
0.38%
|
190,935
|
$18,874,000 | — | 31 Dec 2017 | |
| Redwood Investments, LLC |
13F
|
Company |
0.36%
|
179,595
|
$17,753,000 | — | 31 Dec 2017 | |
| Bank of New York Mellon Corp |
13F
|
Company |
0.36%
|
176,466
|
$17,443,000 | — | 31 Dec 2017 | |
| TEACHERS ADVISORS, LLC |
13F
|
Company |
0.33%
|
163,837
|
$16,195,000 | — | 31 Dec 2017 | |
| CHARLES SCHWAB INVESTMENT MANAGEMENT INC |
13F
|
Company |
0.28%
|
140,198
|
$13,859,000 | — | 31 Dec 2017 | |
| ASCEND CAPITAL, LLC |
13F
|
Company |
0.26%
|
130,971
|
$12,947,000 | — | 31 Dec 2017 | |
| Invesco Ltd. |
13F
|
Company |
0.26%
|
129,447
|
$12,796,000 | — | 31 Dec 2017 | |
| TIAA CREF INVESTMENT MANAGEMENT LLC |
13F
|
Company |
0.24%
|
117,071
|
$11,572,000 | — | 31 Dec 2017 | |
| CALIFORNIA PUBLIC EMPLOYEES RETIREMENT SYSTEM |
13F
|
Company |
0.23%
|
113,533
|
$11,223,000 | — | 31 Dec 2017 | |
| JPMORGAN CHASE & CO |
13F
|
Company |
0.22%
|
109,039
|
$10,779,000 | — | 31 Dec 2017 | |
| RICE HALL JAMES & ASSOCIATES, LLC |
13F
|
Company |
0.21%
|
106,272
|
$10,505,000 | — | 31 Dec 2017 | |
| TWO SIGMA ADVISERS, LP |
13F
|
Company |
0.15%
|
76,300
|
$7,542,000 | — | 31 Dec 2017 | |
| FEDERATED HERMES, INC. |
13F
|
Company |
0.15%
|
75,853
|
$7,497,000 | — | 31 Dec 2017 | |
| CASTLEARK MANAGEMENT LLC |
13F
|
Company |
0.14%
|
68,985
|
$6,819,000 | — | 31 Dec 2017 |
Institutional Holders of PUMA BIOTECHNOLOGY, INC. - Common Stock (PBYI) as of Q1 2018
As of 31 Mar 2018,
PUMA BIOTECHNOLOGY, INC. - Common Stock (PBYI) was held by
168 institutional
shareholders
that filed Form 13F with the SEC.
Together, they reported ownership of
35,574,353 shares.
The largest 10 holders included
JANUS HENDERSON GROUP PLC, VANGUARD GROUP INC, ORBIMED ADVISORS LLC, BlackRock Inc., Partner Fund Management, L.P., FMR LLC, STATE STREET CORP, D. E. Shaw & Co., Inc., Point72 Asset Management, L.P., and Redmile Group, LLC.
This page lists
168
institutional shareholders reporting positions in this security
for the Q1 2018 filing period.
| Investor | Option | Weight % | Change % | Value $ | * Price | Shares | Share Change | Activity | Report Period |
|---|
Compare Q1 2018 vs Q4 2017 Across Filers
Q4 2017 holders
194
Q1 2018 holders
168
Holder diff
-26
| Investor | Q4 2017 Shares | Q1 2018 Shares | Share Diff | Share Chg % | Q4 2017 Value $ | Q1 2018 Value $ | Value Diff $ | Value Chg % |
|---|
Trend: ostatnie 8 kwartałów (+ wybrane okresy porównania).
Quarterly Holders Trend
Quarterly Value Trend
Quarterly Shares Trend
* Reported Price is the price of the security as of the portfolio date. This value is significant in that it is the last known price at which the security was still held.
An asterisk sign (*) next to the price indicates that the price is likely invalid.
An asterisk sign (*) next to the price indicates that the price is likely invalid.